Navigation Links
Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings

eaders not to place undue reliance on any forward-looking statements which speak only as of the date they are made. We disclaim any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.

    Contact:

    Lynn Kettleson

    Clarke Communication Group

    

    (617) 512-5922
lkettleson@clarkecommgroup.com

CONTACT: Lynn Kettleson of Clarke Communication Group, +1-617-512-5922, or, for Advanced Magnetics, Inc. lkettleson@clarkecommgroup.com

Web site: http://www.advancedmagnetics.com/

Ticker Symbol: (NASDAQ-NMS:AMAG)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer

Post Your Comments:
(Date:11/30/2009)..., Nov. 30 MedPro Imaging, a premiu...ions, will showcase leading ultrasound solutions i...mens X300 Premium Edition during the company,s deb...(RSNA) conference, being held in Chicago November ...ing markets ultrasound products and services in 17...
(Date:11/30/2009)...TA, Nov. 30 Amoena USA Corporation... products, is sponsoring the 4th Annual Breast Can... Amoena will honor survivors and the people who he...in for the one with the most inspirational story t... to hear about young mothers who bravely endured t...
(Date:11/30/2009)...EL AVIV, Israel, November 30 Optoa...II(TM) dual channel microphone, the most advanced,... magnetic resonance imaging,(fMRI) environments. ,...major step forward for fiber,optic microphone tech..., with,low-latency adaptive noise cancelling. The ...
Breaking Medicine Technology:MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2IDEXX Laboratories to Release 2009 Third Quarter Financial Results 14472 1Pelleve 28TM 29 Wrinkle Treatment System Featured On Beauty Spaces TV Show 5489 1Pelleve 28TM 29 Wrinkle Treatment System Featured On Beauty Spaces TV Show 5489 2National Long Term Care Leaders Praise Senator Snowes Recognition of Nursing Homes Unique Funding Challenges in Caring for Nations Seniors 5486 1National Long Term Care Leaders Praise Senator Snowes Recognition of Nursing Homes Unique Funding Challenges in Caring for Nations Seniors 5486 2
...ng the effects of stem cell source and patient age...lored at a press conference taking place on Sunday... Meeting of the American Society of Hematology in ...y examining a specialized technique for increasing...splantation will also be shared during the press c...
... , , SAN FRANCISCO, Dec. 6 Sanofi-aventis to...udy presented at the 50th Annual Meeting of the Am...atients with hematological malignancies at high or...onstrated that Elitek(R) (rasburicase) significant...to allopurinol alone (p=0.0012). The study also c...
Other Medicine Technology:Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 2Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 3Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 4Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 5Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 6Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 7Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 8Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 2Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 3Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 4Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 5
(Date:11/30/2009)... results in animals , , MONDAY, Nov. 3...uggest that stem cells from transplanted human-der...ng and heart disorders. , Scientists already k...long list of different kinds of cells in the labor...nter in Seoul, Korea, co-author of one of the stud...
(Date:11/30/2009)... Kemin Foods, L.C. ("Kemin") and Om...Health Technologies, Ltd. ("OmniActive") have reac...arties agree that Kemin,s US Patent No. 5,382,714 ... Purification and Recrystallization of Lutein from...nd the reissues of that patent are valid and enfor...
(Date:11/30/2009)...v. 30 During this time of year, pe...For a loved one with Alzheimer,s disease or other ...times struggle with appropriate gift items. ,, ...iders of senior living residences in the nation, i...hese suggestions. ,, A listening device with r...
(Date:11/30/2009)...y (EAU) and Europa Uomo, the European,advocacy mo... entered into an,affiliated partnership as part o...ve,patient awareness in Europe with regards to ur...sson, Secretary-General of the EAU: "Thanks to thi...will gain access to the latest information on,opt...
(Date:11/30/2009)...as launched a series of clinical trials in order t...t. This approach involves the application of perso...cells from the patient him or herself and designed...ve and frequent malignant tumours. The new therapy...d with the standard, first-line treatment involvin...
Breaking Medicine News(10 mins):Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6
...rch 7 IPC The,Hospitalist Company, Inc. (Nasdaq: ...y focused on the delivery of hospitalist medicine ...ts for its fourth quarter and,year-end 2007 on Thu...and will be hosted by Adam Singer,Chairman, Chief ...
...008--Worldwide, an average 95.4 percent of LASIK p...ding to the first review of the world body of scie...t and Refractive Surgery (ASCRS) announced today. ...onsidered among the most successful elective proce...
...matoid arthritis (RA),treatment market, held back ...d the withdrawal of Vioxx and Bextra, is reboundin...he market for prescription drugs to,treat RA toppe...rt by Kalorama Information, Worldwide Market for,R...
...ng Bi-Partisan Senate Letter, asks Lawmakers,to Re...ize Care, and Make,Reform Much More Difficult to A...e Oxygen Community, WASHINGTON, March 7 The Coun... to,approximately 650,000 chronically ill home oxy...
...evelopmental neurobiology at the Medical College o...holar in Neuroscience, has received the 2008 Mathi...e annual award, administered by Foundation for Adv...nce. , Dr. Mei will discuss his studies of neural...
...nic prescriptions in Michigan generated by ...T, March 7 According to new data released today,m...prescriptions written in,the state of Michigan in ...tion in the adoption and utilization of,ePrescribi...
Other Medicine News:Health News:IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results 2Health News:LASIK patients report more than 95 percent satisfaction rate worldwide 2Health News:LASIK patients report more than 95 percent satisfaction rate worldwide 3Health News:LASIK patients report more than 95 percent satisfaction rate worldwide 4Health News:In Post-Vioxx Era, Biologics are Reviving the Arthritis Treatment Market 2Health News:Bi-Partisan Members of U.S. House of Representatives Formally Oppose Funding Reductions to Medicare's Home Oxygen Benefit 2Health News:Bi-Partisan Members of U.S. House of Representatives Formally Oppose Funding Reductions to Medicare's Home Oxygen Benefit 3Health News:Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences 2Health News:Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences 3Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 2Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 3Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 4Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 5Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 6
Replacement Burr/Chuck
Diamond Burr - Disk
Muldoon Lacrimal Dilator
Wilder Lacrimal Dilator - Medium
Medicine Products: